215 related articles for article (PubMed ID: 23216938)
21. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
[TBL] [Abstract][Full Text] [Related]
22. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
Ban-Hoefen M; Francis C
Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
[TBL] [Abstract][Full Text] [Related]
23. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
Papadopoulos S; Flynn JD; Lewis DA
Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
[TBL] [Abstract][Full Text] [Related]
24. Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy.
Modi C; Satani D; Cervellione KL; Cervantes J; Gintautas J
Proc West Pharmacol Soc; 2009; 52():5-7. PubMed ID: 22128408
[TBL] [Abstract][Full Text] [Related]
25. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Lobo B; Finch C; Howard A; Minhas S
Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
[TBL] [Abstract][Full Text] [Related]
26. Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report.
Dracopoulos S; Vougas V; Kassimatis TI; Theodoridis T; Ali ME; Apostolou T
Transplant Proc; 2007 Dec; 39(10):3481-4. PubMed ID: 18089414
[TBL] [Abstract][Full Text] [Related]
27. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
[No Abstract] [Full Text] [Related]
28. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
Snodgrass MN; Shields J; Rai H
Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman.
Leporini C; Rende A; Sorrentino A; Rizzica E; Russo E; Gallelli L; De Sarro G
J Clin Pharmacol; 2013 Sep; 53(9):999-1002. PubMed ID: 23832870
[No Abstract] [Full Text] [Related]
30. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
[TBL] [Abstract][Full Text] [Related]
31. Heparin-induced thrombocytopenia with acute aortic and renal thrombosis in a patient treated with low-molecular-weight heparin.
Chevalier J; Ducasse E; Dasnoy D; Puppinck P
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):209-12. PubMed ID: 15649731
[TBL] [Abstract][Full Text] [Related]
32. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
Matsuo T; Wanaka K; Walenga JM
Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
[TBL] [Abstract][Full Text] [Related]
34. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
He Y; He H; Liu D; Long Y; Su L; Cheng W
Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
[TBL] [Abstract][Full Text] [Related]
35. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
[TBL] [Abstract][Full Text] [Related]
36. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
[TBL] [Abstract][Full Text] [Related]
37. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Rota E; Bazzan M; Fantino G
Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
[No Abstract] [Full Text] [Related]
38. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
Charif R; Davenport A
Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
[TBL] [Abstract][Full Text] [Related]
39. A case of probable bemiparin-induced HIT type II managed with low-dose fondaparinux.
Koufakis T; Tsapakidis K; Margaritis A; Gabranis I
J Postgrad Med; 2015; 61(2):109. PubMed ID: 25766343
[No Abstract] [Full Text] [Related]
40. Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II.
Haase M; Bellomo R; Rocktaeschel J; Ziemer S; Kiesewetter H; Morgera S; Neumayer HH
Nephrol Dial Transplant; 2005 Feb; 20(2):444-6. PubMed ID: 15673695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
